Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
- 6 February 2016
- journal article
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 16 (3), 261-274
- https://doi.org/10.2174/1568009616666151106120434